Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-25 @ 9:43 PM
Study NCT ID:
NCT01340651
Status:
COMPLETED
Last Update Posted:
2014-03-10
First Post:
2011-04-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-21
First Submit QC Date:
None
Study First Post Date:
2011-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-07-23
Results First Submit QC Date:
None
Results First Post Date:
2013-09-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-05
Last Update Post Date:
2014-03-10
Last Update Post Date Type:
ESTIMATED